跳至主要内容
临床试验/NCT01251224
NCT01251224已完成3 期

Mouse Allergen and Asthma Intervention Trial

Johns Hopkins University4 个研究点 分布在 1 个国家目标入组 361 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
361
试验地点
4
主要终点
change in asthma symptoms

研究概览

简要总结

The MAAIT is a randomized, controlled trial of a home intervention to reduce mouse allergen exposure in mouse allergic children with asthma and mouse allergen exposure. Participants will be randomized to either the Integrated Pest Management (IPM) Group or the Education Group. The IPM Group will receive professional mouse abatement, education, two HEPA filters, allergen-proof mattress and pillow encasements, and targeted cleaning. The Education Group will receive education about IPM at the beginning of the trial and then after completion of the trial, will receive the IPM intervention. Participants will be followed for 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • persistent asthma
  • exacerbation, previous 12 months
  • evidence of mouse sensitization
  • high levels of mouse allergen in home
  • ages 5-17 years

排除标准

  • intermittent asthma
  • no exacerbation in previous 12 months
  • not sensitized to mouse
  • low or undetectable mouse allergen in home
  • other lung disease aside from asthma

结局指标

主要结局

change in asthma symptoms

时间窗: 0, 3, 6, 9, 12 months

days of asthma symptoms

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elizabeth Matsui

Associate Professor

Johns Hopkins University

研究点 (4)

Loading locations...

相似试验

Mouse Allergen and Asthma Intervention Trial | 临床试验